BlackRock’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.29M Buy
758,630
+38,339
+5% +$298K ﹤0.01% 3802
2025
Q4
$5.09M Buy
720,291
+60,894
+9% +$470K ﹤0.01% 3835
2025
Q3
$4.92M Sell
659,397
-183,212
-22% -$1.39M ﹤0.01% 3790
2025
Q2
$6.19M Buy
842,609
+295,399
+54% +$2.58M ﹤0.01% 3673
2025
Q1
$4.22M Buy
547,210
+15,530
+3% +$170K ﹤0.01% 3707
2024
Q4
$6.43M Buy
531,680
+17,259
+3% +$221K ﹤0.01% 3623
2024
Q3
$6.45M Buy
514,421
+14,932
+3% +$193K ﹤0.01% 3602
2024
Q2
$5.96M Buy
499,489
+327,687
+191% +$4.5M ﹤0.01% 3630
2024
Q1
$3M Sell
171,802
-10,355
-6% -$187K ﹤0.01% 3860
2023
Q4
$4.68M Buy
182,157
+171,906
+1,677% +$2.44M ﹤0.01% 3716
2023
Q3
$74.2K Buy
10,251
+7
+0.1% +$47 ﹤0.01% 4918
2023
Q2
$54K Sell
10,244
-1,083
-10% -$3.88K ﹤0.01% 5051
2023
Q1
$35.2K Sell
11,327
-12,588
-53% -$47.8K ﹤0.01% 5175
2022
Q4
$94.6K Sell
23,915
-25
-0.1% -$102 ﹤0.01% 5061
2022
Q3
$90K Buy
23,940
+429
+2% +$5.45K ﹤0.01% 5204
2022
Q2
$314K Sell
23,511
-10,300
-30% -$68.5K ﹤0.01% 4910
2022
Q1
$168K Sell
33,811
-494
-1% -$2.45K ﹤0.01% 5148
2021
Q4
$235K Sell
34,305
-1,791
-5% -$30.6K ﹤0.01% 5074
2021
Q3
$1.11M Sell
36,096
-1,614
-4% -$53.1K ﹤0.01% 4523
2021
Q2
$1.23M Sell
37,710
-182,524
-83% -$6.26M ﹤0.01% 4450
2021
Q1
$8.32M Buy
220,234
+40,581
+23% +$1.85M ﹤0.01% 3682
2020
Q4
$8.5M Buy
179,653
+9,454
+6% +$409K ﹤0.01% 3453
2020
Q3
$5.49M Buy
170,199
+25,403
+18% +$994K ﹤0.01% 3534
2020
Q2
$6.38M Buy
144,796
+107,363
+287% +$5.04M ﹤0.01% 3425
2020
Q1
$1.23M Buy
37,433
+1,275
+4% +$58.6K ﹤0.01% 3812
2019
Q4
$1.85M Sell
36,158
-44
-0.1% -$1.84K ﹤0.01% 3817
2019
Q3
$1.33M Sell
36,202
-609
-2% -$32.8K ﹤0.01% 3878
2019
Q2
$2.03M Sell
36,811
-72,934
-66% -$4.56M ﹤0.01% 3779
2019
Q1
$6.67M Sell
109,745
-3,126
-3% -$201K ﹤0.01% 3304
2018
Q4
$6.68M Buy
112,871
+5,212
+5% +$384K ﹤0.01% 3285
2018
Q3
$8.7M Buy
107,659
+4,058
+4% +$322K ﹤0.01% 3290
2018
Q2
$9.07M Buy
103,601
+78,781
+317% +$13.8M ﹤0.01% 3278
2018
Q1
$4.8M Buy
24,820
+1,692
+7% +$316K ﹤0.01% 3437
2017
Q4
$2.37M Hold
23,128
﹤0.01% 3648
2017
Q3
$877K Hold
23,128
﹤0.01% 3944
2017
Q2
$806K Buy
23,128
+21,867
+1,734% +$785K ﹤0.01% 3900
2017
Q1
$89K Buy
+1,261
New +$73.6K ﹤0.01% 4354

Other funds holding GYRE